RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
Articolo
Data di Pubblicazione:
2022
Abstract:
Although chemotherapy, biological agents, and radiotherapy (RT) are cornerstones of the treatment of multiple myeloma (MM), the literature regarding the possible interactions of concurrent systemic treatment (CST) and RT is limited, and the optimal RT dose is still unclear.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
biologic therapy; chemotherapy; concurrent; disease control; immunotherapy; multiple myeloma; myeloma; pain control; radiotherapy; toxicity
Elenco autori:
Guerini, Andrea Emanuele; Tucci, Alessandra; Alongi, Filippo; Mataj, Eneida; Belotti, Angelo; Borghetti, Paolo; Triggiani, Luca; Pegurri, Ludovica; Pedretti, Sara; Bonù, Marco; Tomasini, Davide; Imbrescia, Jessica; Donofrio, Alessandra; Facheris, Giorgio; Singh, Navdeep; Volpi, Giulia; Tomasi, Cesare; Magrini, Stefano Maria; Spiazzi, Luigi; Buglione, Michela
Link alla scheda completa:
Pubblicato in: